Deutsche Bank Ag\ Eye Point Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$212 Billion
Q1 2024

A detailed history of Deutsche Bank Ag\ transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 835,722 shares of EYPT stock, worth $7.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

835,722

Previous 770,503 8.46%

Holding current value

$7.27 Million

Previous $17.8 Million 2.99%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$19.93 - $29.71 $1.3 Million - $1.94 Million	65,219 Added 8.46%	835,722 $17.3 Million
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $4.28 Million - $18.1 Million	748,739 Added 3440.26%	770,503 $17.8 Million
Q3 2023 Nov 09, 2023	BUY	$7.99 - $15.36 $6,631 - $12,748	830 Added 3.96%	21,764 $173,000
Q2 2023 Aug 14, 2023	SELL	$3.03 - $9.0 $12,016 - $35,694	-3,966 Reduced 15.93%	20,934 $182,000
Q1 2023 May 15, 2023	BUY	$2.28 - $5.04 $33,044 - $73,044	14,493 Added 139.26%	24,900 $73,000

Q4 2022 Feb 13, 2023	BUY	$2.37 - $7.2 $414 - $1,260	175 Added 1.71%	10,407 $36,000
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.12 $12,131 - $19,382	-1,743 Reduced 14.56%	10,232 $81,000
Q2 2022 Aug 11, 2022	BUY	$7.25 - $12.71 $3,784 - $6,634	522 Added 4.56%	11,975 $94,000
Q1 2022 May 13, 2022	SELL	$8.67 - $14.11 $11,981 - $19,500	-1,382 Reduced 10.77%	11,453 $139,000
Q4 2021 Feb 11, 2022	SELL	$10.18 - $18.4 $2.06 Million - $3.72 Million	-202,364 Reduced 94.04%	12,835 $157,000
Q3 2021 Nov 04, 2021	SELL	$7.51 - $11.72 $2,906 - $4,535	-387 Reduced 0.18%	215,199 $2.24 Million
Q2 2021 Aug 11, 2021	BUY	$8.69 - $11.08 $1.87 Million - $2.39 Million	215,586 New	215,586 $1.94 Million

Others Institutions Holding EYPT

# of Institutions

176

Shares Held

53.9M

Call Options Held

764K

Put Options Held

1.57M

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account